Search research articles
Contact Us
Filters
Showing results (171-180 of 186) with videos related to
Page
of 19
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
March 21, 2012
Indole-propionic acid derivatives as potent, S1P3-sparing and EAE efficacious sphingosine-1-phosphate 1 (S1P1) receptor agonists
Qinghua Meng, Baowei Zhao, Qiongfeng Xu, et al.
ACS Medicinal Chemistry Letters
|
April 21, 2016
Discovery of CNS Penetrant CXCR2 Antagonists for the Potential Treatment of CNS Demyelinating Disorders
Heng Xu, Hongfu Lu, Zhongmiao Xu, et al.
ACS Medicinal Chemistry Letters
|
February 20, 2018
From RORγt Agonist to Two Types of RORγt Inverse Agonists
Yonghui Wang, Wei Cai, Ting Tang, et al.
Journal of Medicinal Chemistry
|
March 5, 2004
Evaluation of potent and selective small-molecule antagonists for the CXCR2 chemokine receptor
Katherine L Widdowson, John D Elliott, Daniel F Veber, et al.
Bioorganic & Medicinal Chemistry
|
August 17, 2015
Discovery of N-(4-aryl-5-aryloxy-thiazol-2-yl)-amides as potent RORγt inverse agonists
Yonghui Wang, Ting Yang, Qian Liu, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
March 29, 2023
A phosphoglycerate mutase 1 allosteric inhibitor overcomes drug resistance to EGFR-targeted therapy via disrupting IL-6/JAK2/STAT3 signaling pathway in lung adenocarcinoma
Qian Liang, Miaomiao Gong, Jing-Hua Zou, et al.
Journal of Medicinal Chemistry
|
April 17, 2012
Discovery of novel 1,2,4-thiadiazole derivatives as potent, orally active agonists of sphingosine 1-phosphate receptor subtype 1 (S1P(1))
Feng Ren, Guanghui Deng, Hailong Wang, et al.
ACS Medicinal Chemistry Letters
|
July 21, 2015
Discovery of Biaryl Amides as Potent, Orally Bioavailable, and CNS Penetrant RORγt Inhibitors
Yonghui Wang, Wei Cai, Yaobang Cheng, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Discovery of Tertiary Amine and Indole Derivatives as Potent RORγt Inverse Agonists
Ting Yang, Qian Liu, Yaobang Cheng, et al.
Cancer Research
|
October 4, 2022
Metabolic and Nonmetabolic Functions of PSAT1 Coordinate Signaling Cascades to Confer EGFR Inhibitor Resistance and Drive Progression in Lung Adenocarcinoma
Ming-Yu Luo, Ye Zhou, Wei-Ming Gu, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 186) with videos related to
Sort By:
Page
of 19
Bioorganic & Medicinal Chemistry Letters
|
March 21, 2012
Indole-propionic acid derivatives as potent, S1P3-sparing and EAE efficacious sphingosine-1-phosphate 1 (S1P1) receptor agonists
Qinghua Meng, Baowei Zhao, Qiongfeng Xu, et al.
ACS Medicinal Chemistry Letters
|
April 21, 2016
Discovery of CNS Penetrant CXCR2 Antagonists for the Potential Treatment of CNS Demyelinating Disorders
Heng Xu, Hongfu Lu, Zhongmiao Xu, et al.
ACS Medicinal Chemistry Letters
|
February 20, 2018
From RORγt Agonist to Two Types of RORγt Inverse Agonists
Yonghui Wang, Wei Cai, Ting Tang, et al.
Journal of Medicinal Chemistry
|
March 5, 2004
Evaluation of potent and selective small-molecule antagonists for the CXCR2 chemokine receptor
Katherine L Widdowson, John D Elliott, Daniel F Veber, et al.
Bioorganic & Medicinal Chemistry
|
August 17, 2015
Discovery of N-(4-aryl-5-aryloxy-thiazol-2-yl)-amides as potent RORγt inverse agonists
Yonghui Wang, Ting Yang, Qian Liu, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
March 29, 2023
A phosphoglycerate mutase 1 allosteric inhibitor overcomes drug resistance to EGFR-targeted therapy via disrupting IL-6/JAK2/STAT3 signaling pathway in lung adenocarcinoma
Qian Liang, Miaomiao Gong, Jing-Hua Zou, et al.
Journal of Medicinal Chemistry
|
April 17, 2012
Discovery of novel 1,2,4-thiadiazole derivatives as potent, orally active agonists of sphingosine 1-phosphate receptor subtype 1 (S1P(1))
Feng Ren, Guanghui Deng, Hailong Wang, et al.
ACS Medicinal Chemistry Letters
|
July 21, 2015
Discovery of Biaryl Amides as Potent, Orally Bioavailable, and CNS Penetrant RORγt Inhibitors
Yonghui Wang, Wei Cai, Yaobang Cheng, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Discovery of Tertiary Amine and Indole Derivatives as Potent RORγt Inverse Agonists
Ting Yang, Qian Liu, Yaobang Cheng, et al.
Cancer Research
|
October 4, 2022
Metabolic and Nonmetabolic Functions of PSAT1 Coordinate Signaling Cascades to Confer EGFR Inhibitor Resistance and Drive Progression in Lung Adenocarcinoma
Ming-Yu Luo, Ye Zhou, Wei-Ming Gu, et al.
Page
of 19